Methods for treating cancer with anti-gd2/gd3 antibodies
OwnerHoracio Uri SARAGOVIinventor
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods for treatment and prevention of cancer comprising administration of certain monoclonal antibodies and antigen-binding fragments thereof that specifically bind to gangliosides (e.g., GD2 and/or GD3). There are also provided methods comprising administration of certain monoclonal antibodies and antigen-binding fragments thereof that specifically bind to gangliosides (e.g., GD2 and/or GD3) as an adjuvant therapy for cancer.
Claims30
A method for prevention or treatment of a cancer in a subject in need thereof, comprising administration of a therapeutically effective amount of an antibody specific for GD2 and/or GD3 or an antigen-binding fragment thereof to the subject, such that the cancer is prevented or treated.
-4. (canceled)
-10. (canceled)
A method of selecting and treating a subject suffering from an immune checkpoint inhibitor (ICI)-blockade therapy-resistant tumor or cancer, the method comprising the steps of:
- (a) selecting the subject as having an ICI-blockade therapy-resistant tumor or cancer based on the presence of GD2 and/or GD3 on the tumor or cancer cells, or in a liquid biopsy from the subject;
- and
- (b) administering to the selected subject a therapeutically effective amount of an antibody specific for GD2 and/or GD3 or an antigen-binding fragment thereof.
A method of selecting a subject suffering from an immune checkpoint inhibitor (ICI)-blockade therapy-resistant tumor or cancer, the method comprising the steps of:
- (a) obtaining a sample from the subject;
- (b) assaying the sample for binding to an antibody specific for GD2 and/or GD3, wherein the sample that binds the antibody is respectively GD2+ and/or GD3+;
- and
- (c) selecting the subject as suffering from an ICI-blockade therapy-resistant tumor or cancer if the sample is GD2+ and/or GD3+,
- optionally wherein the sample comprises tumor or cancer cells or a biopsy, such as a liquid biopsy, such as blood or serum.
(canceled)
-20. (canceled)
-25. (canceled)
-29. (canceled)
(canceled)
-41. (canceled)
-44. (canceled)
(canceled)
Dependencies are inferred from the claim text.